About
Elgia Therapeutics discovers and develops small molecule therapies targeting metabolic inflammation and fibrosis by leveraging novel biological insights on caspase and kinase molecular targets involved in chronic diseases.
Explore Elgia Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.